Efficacy and Safety Study of Ticagrelor

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

Also called NCT01812330

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01812330
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01812330. Randomized; single masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety Study of Ticagrelor
Condition
Acute Coronary Syndrome
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Ticagrelor
Lead sponsor
General Hospital of Chinese Armed Police Forces (class: other)

Record details

Record id
cardio:ct-nct01812330
Content hash
65296e42a575242f81103ddc310e8b80bfbe06982c39a9fd3302e5d541538581